1. Home
  2. LGND vs ENVA Comparison

LGND vs ENVA Comparison

Compare LGND & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • ENVA
  • Stock Information
  • Founded
  • LGND 1987
  • ENVA 2011
  • Country
  • LGND United States
  • ENVA United States
  • Employees
  • LGND 68
  • ENVA N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • ENVA Finance: Consumer Services
  • Sector
  • LGND Health Care
  • ENVA Finance
  • Exchange
  • LGND Nasdaq
  • ENVA Nasdaq
  • Market Cap
  • LGND 2.2B
  • ENVA 2.7B
  • IPO Year
  • LGND 1992
  • ENVA N/A
  • Fundamental
  • Price
  • LGND $147.40
  • ENVA $104.12
  • Analyst Decision
  • LGND Strong Buy
  • ENVA Buy
  • Analyst Count
  • LGND 8
  • ENVA 7
  • Target Price
  • LGND $144.71
  • ENVA $126.33
  • AVG Volume (30 Days)
  • LGND 139.7K
  • ENVA 360.6K
  • Earning Date
  • LGND 08-05-2025
  • ENVA 07-24-2025
  • Dividend Yield
  • LGND N/A
  • ENVA N/A
  • EPS Growth
  • LGND N/A
  • ENVA 57.71
  • EPS
  • LGND N/A
  • ENVA 9.37
  • Revenue
  • LGND $181,488,000.00
  • ENVA $1,363,816,000.00
  • Revenue This Year
  • LGND $18.41
  • ENVA $161.66
  • Revenue Next Year
  • LGND $18.87
  • ENVA $15.36
  • P/E Ratio
  • LGND N/A
  • ENVA $10.98
  • Revenue Growth
  • LGND 53.40
  • ENVA 21.96
  • 52 Week Low
  • LGND $81.74
  • ENVA $72.87
  • 52 Week High
  • LGND $129.90
  • ENVA $119.06
  • Technical
  • Relative Strength Index (RSI)
  • LGND 68.73
  • ENVA 41.07
  • Support Level
  • LGND $132.21
  • ENVA $102.43
  • Resistance Level
  • LGND $149.21
  • ENVA $106.00
  • Average True Range (ATR)
  • LGND 5.37
  • ENVA 3.13
  • MACD
  • LGND 0.53
  • ENVA -1.04
  • Stochastic Oscillator
  • LGND 83.70
  • ENVA 16.64

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

Share on Social Networks: